Literature DB >> 23374515

Pterygium recurrence related to its size and corneal involvement.

Pir Salim Mahar1, Nabeel Manzar.   

Abstract

OBJECTIVE: To establish the usefulness of grading system based on the size and extent of corneal involvement in predicting recurrence in patients undergoing primary pterygium excision with intraoperative use of adjunctive topical Mitomycin-C (MMC). STUDY
DESIGN: A case series. PLACE AND DURATION OF STUDY: Section of Ophthalmology, the Aga Khan University Hospital, Karachi, from 2005 till 2010.
METHODOLOGY: One hundred and twenty male patients (120 eyes) underwent surgical removal of pterygium using bare sclera method with MMC in concentration of 0.2 mg/ml (0.02%) with exposure time of 3 minutes. Classification of subjects was done according to the grading of pterygium. Patients were followed at 3 months interval for a minimum period of 1 year to record any recurrence.
RESULTS: The pterygium recurrence rate was 6.7% at a follow-up of 1 year. There was no significant association of pterygium recurrence with younger age (p = 0.14). A higher level of corneal involvement by the pterygium at presentation correlated significantly with the recurrence (p = 0.01).
CONCLUSION: These results suggest that a higher grade of pterygium at presentation in patients leads to increased rate of recurrence after surgical excision. Hence, early excision of pterygium is recommended to decrease its recurrence rate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23374515     DOI: 02.2013/JCPSP.120123

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  13 in total

1.  Conjunctival autograft in primary and recurrent pterygium: a study.

Authors:  Kavita Mallikarjun Salagar; Kalyanappa Gurlingappa Biradar
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 2.  Mitomycin C in pterygium treatment.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Milton Ruiz Alves; Roger Chammas; Paulo Schor
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

3.  Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-centre investigation.

Authors:  Naser Samadi Aidenloo; Qader Motarjemizadeh; Maryam Heidarpanah
Journal:  Jpn J Ophthalmol       Date:  2018-03-16       Impact factor: 2.447

4.  [Outcome of pterygium excision after various surgical techniques-is excision with simple conjunctival closure still lege artis?]

Authors:  K Eisenmann; F Zeman; H Helbig; M-A Gamulescu; T Barth
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

Review 5.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

6.  Characteristics and recurrence of pterygium in Saudi Arabia: a single center study with a long follow-up.

Authors:  Waleed Alsarhani; Saeed Alshahrani; Mahmood Showail; Nawaf Alhabdan; Osama Alsumari; Abdullah Almalki; Abdulaziz Alsarhani; Adel Alluhaidan; Bader Alqahtani
Journal:  BMC Ophthalmol       Date:  2021-05-11       Impact factor: 2.209

7.  Recurrence rate with use of intraoperative Mitomycin C versus Conjunctival Autograft following pterygium excision.

Authors:  Quratulain Paracha; Mohammad Ayoob; Zafar Dawood; Sajid Ali Mirza
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

8.  Efficacy of Autologous Serum in Fixing Conjunctival Autografts of Various Sizes in Different Types and Grades of Pterygium.

Authors:  Shreya Thatte; Ankita B Dube; Stuti Sharma
Journal:  J Ophthalmic Vis Res       Date:  2019 Apr-Jun

9.  Management of double-head pterygium with conjunctival autograft and primary closure.

Authors:  Tobias Röck; Karl Ulrich Bartz-Schmidt; Daniel Röck
Journal:  Int Med Case Rep J       Date:  2020-04-01

10.  Conjunctival Autograft With Fibrin Glue for Pterygium: A Long Term Recurrence Assessment.

Authors:  Pablo Luis Daponte; Andrea Cigna; Ovidio Lescano; Federico Sipowicz; Brenda Peña; Gabriel Abud; Gabriel Di-Virgilio; Adriana Chirinos; Gustavo Federico Bodino
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.